In line with this theory is the observation that EBV‐transformed B cells elicit cytotoxic CD4+ T‐cell responses, which cannot be mapped to any known EBV antigen, indicating that viral transformation may cause aberrant upregulation of self‐antigens, which may become the target of pathogenic T‐cell responses in MS.93 The gene discussed is CD4; the disease is myeloid sarcoma.